Sun Pharmaceutical Industries Ltd.
Worldwide Sites
Sun Pharma
Focus on
INNOVATIVE SPECIALTY PHARMACEUTICALS
in CHRONIC THERAPIES
at SENSIBLE COSTS READ ABOUT SUN PHARMA
Sun Pharma
State-Of-The-Art
RESEARCH FACILITIES
to develop
TECHNOLOGICALLY COMPLEX GENERICS LEARN ABOUT OUR RESEARCH CAPABILITIES
Sun Pharma
India's
MOST VALUABLE PHARMACEUTICAL COMPANY
by market capitalisation VIEW OUR LATEST RESULTS

Financial Information

12 JUN
FY13 Q4 Earnings Call Transcript
28 MAY
Sun Pharma reports strong performance
20 DEC
Successful acquisition of DUSA Pharmaceuticals, Inc.U.S.A.by our subsidiary
Webcast of Sun Pharma Q4 & FY13 results conference call Read More

Latest News

04 JUN
Sun Pharma gets USFDA nod for testosterone cypionate injection
08 MAY
Sun Pharmas Bigger than Three Rivals Put Together
26 APR
Sun Pharma Cos M-cap Crosses 1-lakh Crore
Read More

Press Releases

12 JUN
Press Release Sun Pharma settles generic Protonix® litigation
29 MAY
Sun Pharma Announces 1:1 Bonus
17 MAY
Sun Pharma to announce Q4 and FY13 results on May 28, 2013
Read More

NEW PRODUCT APPROVALS

13 APR
Sun pharma announces Tentative USFDA approval for generic Januvia & Glumetza
24 MAY
Sun Pharma announces USFDA approval for generic Astelin® Nasal Spray
04 JUN
Sun Pharma announces USFDA approval for generic Depo®-Testosterone Injection
Read More